The Research Informatics group is looking for a software engineer to develop, maintain, and support web applications and tools utilized by Research, Early Development, and other groups within Alnylam. These tools directly support the discovery and development of RNAi therapeutics, enabling scientists to analyze data, make decisions, and accelerate progress toward new medicines. Because RNAi is a relatively new therapeutic modality, much of our work involves building custom software, ranging from data pipelines and APIs to user-facing applications and visualizations.
We are also expanding our internal AI platform, including tools for natural language querying, structured data access (e.g., text-to-SQL), and working with unstructured data. Engineers on the team contribute to these systems and help integrate them into scientific workflows. This role is a good fit for someone early in their career who has some professional experience and is excited to take on increasing ownership, contribute to real-world scientific problems, and grow within a collaborative engineering team.
This position is hybridand will be primarily located in Cambridge, MA.
Key Responsibilities
Qualifications
Required
Preferred
Other
Engineers on this team regularly see their work used directly by scientists and researchers.
#LI-JR1
SILENCE DISEASE. AMPLIFY LIFE.™
Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them.
Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, five more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases.
We are a global and diverse company of 2,600+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-24), Science Magazine (2018-25), Fast Company (Best Workplaces for Innovators 2020-25) and LinkedIn (2024).
We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America.
See our social media community guidelines: https://bit.ly/2FcRhJy.
Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861
Fraudulent Recruitment Activity
Be aware of the potential for scams and fraudulent recruitment activity from individuals claiming to represent Alnylam Pharmaceuticals. Alnylam never conducts its interview process via messaging apps, freelance sites, or social media platforms. Alnylam team members only communicate with potential candidates through an official Alnylam email address ending in "@alnylam.com."
